Literature DB >> 2427795

Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction.

B T Poll-The, J M Saudubray, H Ogier, R B Schutgens, R J Wanders, G Schrakamp, H van den Bosch, J M Trijbels, A Poulos, H W Moser.   

Abstract

Infantile Refsum's disease was diagnosed in three male patients, presenting with facial dysmorphia, retinitis pigmentosa, neurosensory hearing loss, hepatomegaly, osteopenia and delayed growth and psychomotor development. An elevated plasma phytanic acid concentration and a deficient phytanic acid oxidase activity in fibroblasts were found with an accumulation of very long chain fatty acids in plasma and fibroblasts. There were elevated pipecolic acid levels in plasma, urine and CSF, and abnormal bile acid metabolites in plasma. Deficient activity of acylCoA: dihydroxyacetone phosphate acyl transferase was found in thrombocytes and fibroblasts of these patients as well as an impaired de novo plasmalogen biosynthesis in fibroblasts. These biochemical abnormalities, previously described in the Zellweger syndrome, suggest multiple peroxisomal dysfunction in our patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427795     DOI: 10.1007/bf01799455

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  23 in total

1.  Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism.

Authors:  D M Danks; P Tippett; C Adams; P Campbell
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

2.  Refsum's disease, adrenoleucodystrophy, and the Zellweger syndrome.

Authors:  O Stokke; S Skrede; J Ek; I Björkhem
Journal:  Scand J Clin Lab Invest       Date:  1984-09       Impact factor: 1.713

3.  Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.

Authors:  F R Brown; A J McAdams; J W Cummins; R Konkol; I Singh; A B Moser; H W Moser
Journal:  Johns Hopkins Med J       Date:  1982-12

4.  Identification of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestan-26-oic acid, an intermediate in cholic acid synthesis, in the plasma of patients with infantile Refsum's disease.

Authors:  A Poulos; M J Whiting
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

5.  Refsum's disease: nature of the enzyme defect.

Authors:  D Steinberg; J H Herndon; B W Uhlendorf; C E Mize; J Avigan; G W Milne
Journal:  Science       Date:  1967-06-30       Impact factor: 47.728

6.  Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome.

Authors:  R B Schutgens; G J Romeyn; R J Wanders; H van den Bosch; G Schrakamp; H S Heymans
Journal:  Biochem Biophys Res Commun       Date:  1984-04-16       Impact factor: 3.575

7.  Deficiency of plasmalogens in the cerebro-hepato-renal (Zellweger) syndrome.

Authors:  H S Heymans; H vd Bosch; R B Schutgens; W H Tegelaers; J U Walther; J Müller-Höcker; P Borst
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

8.  Diagnosis of Refsum's disease using [1-14C]phytanic acid as substrate.

Authors:  A Poulos
Journal:  Clin Genet       Date:  1981-10       Impact factor: 4.438

9.  Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.

Authors:  H W Moser; A B Moser; K K Frayer; W Chen; J D Schulman; B P O'Neill; Y Kishimoto
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910

10.  Ultrastructural and cytochemical demonstration of peroxisomes in cultured fibroblasts from patients with peroxisomal deficiency disorders.

Authors:  J A Arias; A B Moser; S L Goldfischer
Journal:  J Cell Biol       Date:  1985-05       Impact factor: 10.539

View more
  19 in total

1.  The activity and subcellular distribution of the peroxisomal enzyme acyl-CoA oxidase in human blood platelets.

Authors:  M Farstad; A M Bakken; R K Berge
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

2.  Peroxisomes in infantile phytanic acid storage disease: a cytochemical study of skin fibroblasts.

Authors:  M E Beard; A B Moser; V Sapirstein; E Holtzman
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  Infantile Refsum disease: an inherited peroxisomal disorder. Comparison with Zellweger syndrome and neonatal adrenoleukodystrophy.

Authors:  B T Poll-The; J M Saudubray; H A Ogier; M Odièvre; J M Scotto; L Monnens; L C Govaerts; F Roels; A Cornelis; R B Schutgens
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

4.  Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.

Authors:  B T Poll-The; O H Skjeldal; O Stokke; A Poulos; F Demaugre; J M Saudubray
Journal:  Hum Genet       Date:  1989-01       Impact factor: 4.132

5.  Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.

Authors:  G M Small; M J Santos; T Imanaka; A Poulos; D M Danks; H W Moser; P B Lazarow
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

6.  Detection of peroxisomes in human liver and kidney fixed with formalin and embedded in paraffin: the use of catalase and lipid beta-oxidation enzymes as immunocytochemical markers.

Authors:  J A Litwin; A Völkl; J Stachura; H D Fahimi
Journal:  Histochem J       Date:  1988-03

7.  Phytanic acid attenuates insulin-like growth factor-1 activity via nitric oxide-mediated γ-secretase activation in rat aortic smooth muscle cells: possible implications for pathogenesis of infantile Refsum disease.

Authors:  Gursev S Dhaunsi; Mayra Alsaeid; Saghir Akhtar
Journal:  Pediatr Res       Date:  2016-11-25       Impact factor: 3.756

8.  Localization of pipecolic acid metabolism in rat liver peroxisomes: probable explanation for hyperpipecolataemia in Zellweger syndrome.

Authors:  J M Trijbels; L A Monnens; G Melis; M van den Broekvan Essen; M Bruckwilder
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 9.  Clinical approach to inherited peroxisomal disorders.

Authors:  F Poggi-Travert; B Fournier; B T Poll-The; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

10.  Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.

Authors:  R J Wanders; C W van Roermund; M J van Wijland; R B Schutgens; J Heikoop; H van den Bosch; A W Schram; J M Tager
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.